Clinical Trial Update: CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial of CD34+ enriched transplants to treat myelodysplastic syndromes is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Myelodysplastic Syndromes

Snippet

Sponsor: Guenther Koehne | Conditions: Myelodysplastic Syndromes, Graft Vs Host Disease | Phase 2 | Status: SUSPENDED